| Code | CSB-MP023996HU1c9 |
| Abbreviation | Recombinant Human TNFSF8 protein, partial (Active) |
| MSDS | |
| Size | $136 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CD30 ligand (TNFSF8) drives NF-κB signaling through CD30 engagement on activated T and B cells, making it a critical tool for dissecting lymphocyte activation and Hodgkin lymphoma biology. This recombinant human CD30L, spanning residues 63–234 with an N-terminal hFc tag, demonstrates potent receptor binding with an EC50 of 4.169–6.360 ng/ml against immobilized CD30 in functional ELISA, supporting its use as a coating antigen for antibody screening, a positive control in CD30/CD30L interaction assays, and a stimulus in cell-based activation or proliferation studies using primary lymphocytes. Endotoxin levels below 1.0 EU/μg minimize LPS-driven artifacts in sensitive immune cell experiments, while purity exceeding 90% by SDS-PAGE satisfies the quality thresholds commonly required for in vivo tumor models and NF-κB pathway signaling studies. The hFc fusion format also facilitates straightforward detection and crosslinking in functional assays requiring receptor clustering.
There are currently no reviews for this product.